2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
“2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers” is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 300 pages and 48 tables
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
“2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers” is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 300 pages and 48 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
FRANCE: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
GERMANY: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
ITALY: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
SPAIN: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
UK: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio/Innogenetics
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
13. Tricyclic Antidepressants
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
FRANCE: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
GERMANY: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
ITALY: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
SPAIN: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
UK: TEST VOLUME AND SALES FORECASTS BY ASSAY AND MARKET SEGMENT, AND MAJOR SUPPLIER MARKET SHARES
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio/Innogenetics
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
LIST OF TABLES
Major Companies Developing or Marketing Drugs of Abuse Tests
France, Drugs of Abuse Test Volume Forecast By Market Segment
France, All Market Segments, Drugs Of Abuse Test Volume Forecast by Assay
France, Hospital Laboratories, Drugs Of Abuse Test Volume Forecast by Assay
France, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
France, Drugs of Abuse Reagent Market Forecast By Market Segment
France, All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
France, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
France, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
France, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Germany, Drugs of Abuse Test Volume Forecast By Market Segment
Germany, All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
Germany, Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Germany, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Germany, Physician Offices/Group Practices, Drugs of Abuse Test Volume Forecast by Assay
Germany, Drugs of Abuse Reagent Market Forecast By Market Segment
Germany, All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
Germany, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Germany, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Germany, Physician Offices/Group Practices, Drugs of Abuse Reagent Market Forecast by Assay
Germany, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Italy, Drugs of Abuse Test Volume Forecast By Market Segment
Italy, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Italy, Drugs of Abuse Reagent Market Forecast By Market Segment
Italy, All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
Italy, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Italy, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Italy, All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
Italy, Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Italy, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Spain, Drugs of Abuse Test Volume Forecast By Market Segment
Spain, All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
Spain, Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Spain, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Spain, Ambulatory Care Centers, Drugs of Abuse Test Volume Forecast by Assay
Spain, Drugs of Abuse Reagent Market Forecast By Market Segment
Spain, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Spain, Ambulatory Care Centers, Drugs of Abuse Reagent Market Forecast by Assay
Spain, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
U.K., Drugs of Abuse Test Volume Forecast By Market Segment
U.K., All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
U.K., Drugs of Abuse Reagent Market Forecast By Market Segment
U.K., All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Major Companies Developing or Marketing Drugs of Abuse Tests
France, Drugs of Abuse Test Volume Forecast By Market Segment
France, All Market Segments, Drugs Of Abuse Test Volume Forecast by Assay
France, Hospital Laboratories, Drugs Of Abuse Test Volume Forecast by Assay
France, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
France, Drugs of Abuse Reagent Market Forecast By Market Segment
France, All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
France, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
France, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
France, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Germany, Drugs of Abuse Test Volume Forecast By Market Segment
Germany, All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
Germany, Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Germany, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Germany, Physician Offices/Group Practices, Drugs of Abuse Test Volume Forecast by Assay
Germany, Drugs of Abuse Reagent Market Forecast By Market Segment
Germany, All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
Germany, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Germany, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Germany, Physician Offices/Group Practices, Drugs of Abuse Reagent Market Forecast by Assay
Germany, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Italy, Drugs of Abuse Test Volume Forecast By Market Segment
Italy, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Italy, Drugs of Abuse Reagent Market Forecast By Market Segment
Italy, All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
Italy, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Italy, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Italy, All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
Italy, Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Italy, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Spain, Drugs of Abuse Test Volume Forecast By Market Segment
Spain, All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
Spain, Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Spain, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
Spain, Ambulatory Care Centers, Drugs of Abuse Test Volume Forecast by Assay
Spain, Drugs of Abuse Reagent Market Forecast By Market Segment
Spain, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
Spain, Ambulatory Care Centers, Drugs of Abuse Reagent Market Forecast by Assay
Spain, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
U.K., Drugs of Abuse Test Volume Forecast By Market Segment
U.K., All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
U.K., Drugs of Abuse Reagent Market Forecast By Market Segment
U.K., All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
U.K., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
